No Detail Found!

Clinical efficacy and safety of norepinephrine combined with ulinastatin in the treatment of septic shock

Author(s)
Yanping He Department of Emergency and The Intensive Care Unit, Chongqing Hospital of Traditional Chinese Medicine,Chongqing,China
Xuemei Chen Department of Emergency and The Intensive Care Unit, Chongqing Hospital of Traditional Chinese Medicine,Chongqing,China
Guifang Zhang Department of Emergency and The Intensive Care Unit, Chongqing Hospital of Traditional Chinese Medicine,Chongqing,China
Lijuan Guan Department of Geriatrics, Chengdu Fifth People's Hospital,Chengdu, Sichuan,China
Xie Yu Department of Emergency and The Intensive Care Unit, Chongqing Hospital of Traditional Chinese Medicine,Chongqing,China
Abstract
To analyze the clinical efficacy and safety of norepinephrine combined with ulinastatin in the treatment of septic shock. 100 patients with septic shock treated in our institution from May 2019 to May 2021 were recruited and randomly assigned to receive either norepinephrine (control group) or norepinephrine plus ulinastatin (experimental group) according to the treatment scheme. The treatment efficacy, time for shock improvement, intensive care unit (ICU) stay, total hospital stay, in-hospital mortality, 30-day survival, and changes in inflammatory factors (plasma C-reactive protein (CRP), serum lactic acid (LAC), serum procalcitonin (PCT), and interleukin-10 (IL-10)) before and after treatment were analyzed, and the sequential organ failure scores of the two groups were compared. The experimental group exhibited superior performance with respect to efficacy, ICU stays, and total hospital stay, in-hospital mortality to the control group (all P<0.05). After treatment, the experimental group presented lower levels of CRP, LAC, PCT and IL-10 and higher SOFA scores than the control group (P<0.05). Norepinephrine plus ulinastatin achieved remarkable results in the treatment of septic shock, improving the treatment efficiency, shortening the time for shock improvement and hospitalization, reducing hospital mortality, driving down the expression of inflammatory factors and enhancing the survival of patients, with high safety.
Publication Details
Page(s) 657-663
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: S2, Year: 2022

Request the full text from PASTIC

Keywords
Norepinephrine, Clinical efficacy, Ulinastatin, Septic shock
References
Antal O,Stefanescu E,Hagau N E .2019 .Does norepinephrine infusion dose influence the femoral-toradial mean arterial blood pressure gradient in patients with sepsis and septic shock. , 24(2) : 74-77.
Bredhold BE,Winters SD,Callison JC,Heidel RE,Allen LM,Hamilton LA .2020 .Impact of the sequence of norepinephrine and vasopressin discontinuation in patients recovering from septic shock. Hosp Pharm, 55(1) : 26-31.
Dalla K,Bech-Hanssen O,Ricksten SE .2019 .Impact of norepinephrine on right ventricular afterload and function in septic shock-a strain echocardiography study. Acta Anaesthesiol Scand, 63(10) : 1337-1345.
Duclos G,Baumstarck K,Dunser M,Zieleskiewicz L,Leone M .2019 .Effects of the discontinuation sequence of norepinephrine and vasopressin on hypotension incidence in patients with septic shock: A meta-analysis. Heart Lung, 48(6) : 560-565.
Elbouhy MA,Soliman M,Gaber A,Taema KM,Abdel-Aziz A .2019 .Early use of norepinephrine improves survival in septic shock: Earlier than early. Arch Med Res, 50(6) : 325-332.
Haiduc M,Radparvar S,Aitken SL,Altshuler J .2021 .Does switching norepinephrine to phenylephrine in septic shock complicated by atrial fibrillation with rapid ventricular response improve time to rate control? J. Intensive Care Med. , 36(2) : 191-196.
Hajjar LA,Zambolim C,Belletti A,de Almeida JP,Gordon AC,Oliveira G,Landoni G .2019 .Vasopressin versus norepinephrine for the management of septic shock in cancer patients: The VANCS II randomized clinical trial. Crit Care Med, 47(12) : 1743-1750.
Hammond DA,Ficek OA,Painter JT,McCain K,Cullen J,Brotherton AL,Meena N AL .2018 .Prospective openlabel trial of early concomitant vasopressin and norepinephrine therapy versus initial norepinephrine monotherapy in septic shock. Pharmacotherapy, 38(5) : 531-538.
Hamzaoui O,Jozwiak M,Geffriaud T,Sztrymf B,Prat D,Jacobs F,Teboul JL F .2018 .Norepinephrine exerts an inotropic effect during the early phase of human septic shock. Br. J. Anaesth, 120(3) : 517-524.
Kasugai D,Hirakawa A,Ozaki M,Nishida K,Ikeda T,Takahashi K,Uenishi N K .2020 .Maximum norepinephrine dosage within 24 hours as an indicator of refractory septic shock: A retrospective study. J. Intensive Care Med, 35(11) : 1285-1289.
Morelli A,Sanfilippo F,Arnemann P,Hessler M,Kampmeier TG,D'Egidio A,Ertmer C .2019 .The effect of propofol and dexmedetomidine sedation on norepinephrine requirements in septic shock patients: A crossover trial. Crit Care Med, 47(2) : e89-e95.
Musallam N,Altshuler D,Merchan C,Zakhary B,Aberle C,Papadopoulos J .2018 .Evaluating vasopressor discontinuation strategies in patients with septic shock on concomitant norepinephrine and vasopressin infusions. , 52(8) : 733-739.
Post EH,Su F,Righy Shinotsuka C,Taccone FS,Creteur J,De Backer D,Vincent JL D .2018 .Renal autoregulation in experimental septic shock and its response to vasopressin and norepinephrine administration. J. Appl. Physiol., Online ahead of print., : .
Rizk MY,Lapointe A,Lefebvre F,Barrington KJ .2018 .Norepinephrine infusion improves haemodynamics in the preterm infants during septic shock. Acta Paediatr., 107(3) : 408-413.
Wu Z,Zhang S,Xu J,Xie J,Huang L,Huang Y,Qiu H Y .2020 .Norepinephrine vs vasopressin: Which vasopressor should be discontinued first in septic shock? A meta-analysis. Shock, 53(1) : 50-57.
Zhong L,Ji XW,Wang HL,Zhao GM,Zhou Q,Xie B .2020 .Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials. J. Intensive Care, 8(1) : 83.
0

Citations

0

Downloads

8

Views